Blood Pressure Medication Prazosin Recalled Nationwide Due to Potential Cancer Risk
More than half a million bottles of the blood pressure medication prazosin hydrochloride are being recalled across the United States today, October 31, 2025, due to the potential presence of a cancer-causing chemical.
Teva Pharmaceuticals USA and Amerisource Health Services initiated the voluntary nationwide recall of over 580,000 bottles of various strengths of prazosin capsules earlier this month, according to the U.S. Food and Drug Administration. Prazosin is commonly prescribed to lower blood pressure by relaxing blood vessels and is also sometimes used to treat nightmares associated with post-traumatic stress disorder.
The FDA has classified the affected lots as Class II risk, indicating that exposure to the nitrosamine impurities found in some recalled medication may pose a potential cancer risk. N-nitrosamine impurities, as explained by the FDA, can develop during the manufacturing or storage process of certain drugs. This recall highlights the FDA’s ongoing efforts to protect consumers from potentially harmful contaminants in medications; you can find more information about drug recalls and safety alerts on the FDA website.
The FDA posted enforcement orders online detailing the recall and is urging patients to continue taking their medication until they can consult with their healthcare provider for a potential alternative. Officials stated they will continue to monitor the situation and provide updates as they become available.
